Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Your are on :  Markets   |  News Analysis    |  Stock Alert   |Detailed News   
Back
HDFC Bank, Kotak Mahindra Bank, Cadila Healthcare in focus
31-May-21   08:35 Hrs IST

HDFC Bank informed that the Reserve Bank of India (RBI) has imposed, by an order dated May 27, 2021, a monetary penalty of Rs 10 crore on the bank. As per the said order, the penalty has been imposed for marketing / sale of third party non-financial products in contravention of provisions of Section 6(2) and Section 8 of the Act.

Kotak Mahindra Bank said that its board of directors approved the proposal for issuance of Unsecured, Redeemable, Non-Convertible Debentures/Bonds/other Debt Securities, on private placement basis for an amount upto Rs 5,000 crore, in one or more tranches.

Cadila Healthcare has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg. This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia).

Punjab National Bank informed that the bank intends to divest its stake in Canara HSBC OBC Life Insurance Co. Ltd., an associate company of the Bank, at an appropriate time depending upon market conditions and available options.

On a standalone basis, Bank of Baroda reported a net loss of Rs 1,046.50 crore in Q4 FY21 as against a net profit of Rs 506.59 crore in Q4 FY20. Total income remained almost unchanged at Rs 21,532.91 crore.

On a consolidated basis, Divis Laboratories' net profit surged 29.31% to Rs 502.02 crore on 23.54% increase in total income to Rs 1,811.71 crore in Q4 March 2021 over Q4 March 2020.

On a consolidated basis, Dollar Industries' net profit surged 58.74% to Rs 19.35 crore on 28.87% increase in total income to Rs 310.44 crore in Q4 March 2021 over Q4 March 2020.

On a consolidated basis, Fortis Healthcare reported a net profit of Rs 43.17 crore in Q4 FY21 as against a net loss of Rs 44.51 crore in Q4 FY20. Total income rose 12.73% to Rs 1,277.66 crore.

On a consolidated basis, Affle India's net profit surged 282.67% to Rs 58.51 crore on 112.84% increase in total income to Rs 177.59 crore in Q4 March 2021 over Q4 March 2020.

Powered by Capital Market - Live News

Home About Us Product Disclaimer Markets Research Privacy Policy Careers Contact Us Feedback Scores
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI   |   NSE   |   BSE   |   MCX-SX   |   MCX   |   NCDEX   |   NSDL   |   CDSL   |   FMC
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)